Tabula Rasa HealthCare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tabula Rasa HealthCare generated cash of $7,357,000, which is less than the previous year. Cash used in financing activities reached the amount of -$31,958,000 last year. Net change in cash is therefore $66,701,000.
Cash Flow
| 2013 | -2.15M | -845K | 8.86M |
|---|---|---|---|
| 2014 | 870K | -14.91M | 12.14M |
| 2015 | 3.25M | -3.27M | -2.07M |
| 2016 | 6.77M | -10.89M | 6.44M |
| 2017 | 18.30M | -41.06M | 28.84M |
| 2018 | 15.83M | -43.80M | 42.57M |
| 2019 | -5.81M | -180.92M | 208.29M |
| 2020 | 4.81M | -28.73M | 5.86M |
| 2021 | 15.45M | -35.19M | 6.91M |
| 2022 | 7.35M | 91.30M | -31.95M |
TRHC Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.70M | 28.53M | 46.58M | 25.02M | 10.43M | 4.34M | 2.02M | 4.12M | 6.02M | 159K |
Operating activities | ||||||||||
Net income | -147.51M | -79.05M | -80.96M | -32.43M | -47.26M | 14.29M | -6.25M | -2.86M | -1.10M | -3.87M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 30.67M | 47.70M | 45.04M | 34.27M | 16.80M | 9.51M | 5.11M | 3.93M | 1.81M | 1.11M |
Stock-based compensation expense | 36.83M | 38.45M | 32.55M | 27.27M | 10.36M | 8.75M | 4.25M | 565K | 254K | 89K |
| Deferred income tax benefit | 36.83M | 38.45M | 32.55M | 27.27M | 10.36M | 8.75M | 4.25M | 565K | 254K | 89K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 5.54M | -1.52M | -2.44M | 1.44M | -9.45M | -2.13M | -633K | -1.71M | -1.38M | -884K |
Inventories | -1.12M | -1.18M | -239K | -106K | -799K | 116K | -607K | -264K | -792K | -337K |
Accounts payable | 8.69M | 1.98M | 2.14M | -7.80M | -778K | 1.28M | 665K | 440K | 1.38M | 801K |
Cash generated by operating activities | 7.35M | 15.45M | 4.81M | -5.81M | 15.83M | 18.30M | 6.77M | 3.25M | 870K | -2.15M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -28.73M | -35.19M | -21.92M | -23.16M | -10.57M | -6.61M | -5.69M | -1.17M | -968K | -845K |
Acquisitions Net | 120.03M | 0 | -6.80M | -158.76M | -32.23M | -34.45M | -5.4M | -2.40M | -13.44M | 0 |
Cash generated by investing activities | 91.30M | -35.19M | -28.73M | -180.92M | -43.80M | -41.06M | -10.89M | -3.27M | -14.91M | -845K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 34.89M | 55.18M | 12K | 59K | 164K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -2.18M | -3K | -2.99M | 0 | -2.86M | -959K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -26.54M | -56K | 0 | -1.05M | 0 | -77.95M | 0 | -1.87M | -3.38M |
Cash used in financing activities | -31.95M | 6.91M | 5.86M | 208.29M | 42.57M | 28.84M | 6.44M | -2.07M | 12.14M | 8.86M |
Net Change In Cash | 66.70M | -12.82M | -18.04M | 21.55M | 14.59M | 6.08M | 2.31M | -2.09M | -1.90M | 5.86M |
Cash at end of period | 82.40M | 15.70M | 28.53M | 46.58M | 25.02M | 10.43M | 4.34M | 2.02M | 4.12M | 6.02M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |